TokenPost·
Democratic Senators Ask HHS to Address Drug Trial Market Risks
The letter cites possible effects on trial enrollment decisions and insider trading by researchers or regulators with access to nonpublic information.
More news
- TokenPostGAMCO Trust Sets $0.035 Monthly Cash Distributions for First Quarter of 2027
- TokenPostGabelli Utility Trust Board Declares Three Monthly Distributions of $0.05 per Share
- Crypto BriefingFoxconn expects AI server rack shipments to grow by high double digits in Q4
- CoinDeskCanaan may sell more bitcoin for stock buybacks as mining-rig revenue falls 96%
- Crypto BriefingPIMCO says AI borrowers now drive nearly half of long-dated US investment-grade issuance
- TokenPostJoseph Lubin Says Ether (ETH) Could Serve as a Store of Value